• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    OncoMed Pharmaceuticals, Inc. (OMED)

    -NasdaqGS
    21.48 Up 0.30(1.42%) Dec 19, 4:00PM EST
    |After Hours : 21.48 0.00 (0.00%) Dec 19, 5:00PM EST
    Add to Portfolio
    Prev Close:21.18
    Open:21.13
    Bid:21.48 x 8900
    Ask:21.50 x 2800
    1y Target Est:41.40
    Beta:1.637
    Next Earnings Date:N/A
    Day's Range:21.05 - 21.98
    52wk Range:16.57 - 42.34
    Volume:387,136
    Avg Vol (3m):155,794
    Market Cap:640.79M
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMED

    Comparison

    Symbol% ChgMkt Cap
    OMEDUp 1.42%640.79M
    STMLDown 4.36%201.77M
    VSTMDown 2.31%218.55M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.46
    Quarterly EPS Est (Dec-14) :-0.28
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback